|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06618 JD HEALTH
Nominal 
68.800 +0.450 (+0.658%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 35,290,047 | 24.506% | 28,343,961 | 27,110,336 | 20,225,212 | 13,637,832 |
| Cost of Sales | (26,398,129) | 21.965% | (21,644,018) | (20,907,336) | (15,810,653) | (10,330,373) |
| Gross Profit | 8,891,918 | 32.716% | 6,699,943 | 6,203,000 | 4,414,559 | 3,307,459 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (55,480) | -- | 10,409 | (64,662) | (11,025) | (9,831) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (39,147) | -4.066% | (40,806) | (32,197) | (48,566) | (40,531) | |
| Profit / (Loss) before Taxation | 2,863,666 | 17.395% | 2,439,342 | 1,831,226 | 377,346 | (345,302) | |
| Taxation | (272,319) | -32.755% | (404,964) | (269,234) | (154,388) | (108,911) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 5,098 | 81.812% | 2,804 | (634) | 594 | (931) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,596,445 | 27.453% | 2,037,182 | 1,561,358 | 223,552 | (455,144) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (804,395) | -18.376% | (985,491) | (932,068) | (215,770) | (228,999) |
| Depreciation & Amortisation | 120,347 | 16.595% | 103,218 | 107,930 | 50,984 | 25,810 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 82.000 | 26.154% | 65.000 | 50.000 | 7.000 | -15.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 18.116 | -- | 16.344 | 15.309 | 13.326 | 12.420 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,596,445 |
| %Change | 27.453% |
| EPS / (LPS) | RMB 0.820 |
| NBV Per Share (¥) | RMB 18.116 |